Treatment of Chronic Fatigue Syndrome in the Antiviral Revolution Era

This book addresses the scientific rationale, historical evolution, clinical trials, and lines of research on the use of antiviral agents for the treatment of chronic fatigue syndrome. Treatment of Chronic Fatigue Syndrome in the Antiviral Revolution Era offers proof that viruses may be direct or indirect causes of the disease. This breakthrough book offers updates on specific drugs and treatments, including Acyclovir, Ampligen, Imunovir (Inosine Pranobex), and 2CVV. It also discusses the use of vaccines against Epstein-Barr virus, influenza, staphylococcus, and stealth virus. It is an essential resource for physicians, researchers, virologists, and patient advocates, as well as for anyone who is trying to obtain the best possible treatment for CFS.
To view an excerpt online, find the book in our QuickSearch catalog at www.HaworthPress.com.

Patarca-Montero, Roberto

Contents - Preface - Chapter 1. The Antiviral Era - Chapter 2. Viruses As Potential Direct or Indirect Ethiological Agents for CFS - Viruses As Direct Etiological Agents for CFS - Viruses As Indirect Etiological Agents for CFS - Chapter 3. Viral-Specific and Immune-Based Nonspecific Antiviral Therapies for CFS - Acyclovir and Related Antiherpetic Drugs - Ampligen - 2CVV - Epstein-Barr Virus Vaccine - Imunovir (Inosine Pranobex) - Influenza Virus Vaccine Alone or in Combination with Other Vaccines - Interferon-Alpha - Juzen-Taiho-To - Lymph Node Cell-Based Immunotherapy - Mycobacterium Vaccae - Panax Ginseng - Sizofiran - SPV-30 - Staphylococcal Vaccine - Stealth Virus Vaccine - Thimerosal - Transfer Factors Against Herpesviruses - Chapter 4. Concluding Remarks - Notes - Index